alexa Citalopram improves dexterity in chronic stroke patients.


Journal of Neurology & Neurophysiology

Author(s): Zittel S, Weiller C, Liepert J

Abstract Share this page

Abstract BACKGROUND: A majority of stroke patients have persisting motor deficits despite ongoing physiotherapy. Therefore, additional treatment options are desirable. OBJECTIVE: We investigated if the serotonin reuptake inhibitor, citalopram, would improve motor functions in chronic stroke patients. METHODS: In all, 8 patients >6 months after their stroke participated in a double-blind, placebo-controlled, single-dose crossover experiment. The order (first drug then placebo or vice versa) was randomized. Sessions were separated by at least 2 weeks. Motor function was assessed by nine-hole peg test, and measurements of hand grip-strength before drug intake, 2 hours after drug intake, and after 1 hour of training aimed at improving the function of the paretic hand. RESULTS: Compared with placebo, citalopram intake significantly improved performance of the nine-hole peg test for the paretic hand but not for the unaffected hand. Hand grip-strength remained unchanged. CONCLUSIONS: A single dose of citalopram can enhance dexterity in chronic stroke patients. This pilot study justifies a test of efficacy of citalopram in a larger group of stroke patients. This article was published in Neurorehabil Neural Repair and referenced in Journal of Neurology & Neurophysiology

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version